MBCL-51. POST-AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION (AuHCT) PRACTICES FOR YOUNG CHILDREN WITH MALIGNANT BRAIN TUMORS
Mahvish Q. Rahim, Scott Coven(Nationwide Children's Hospital), Girish Dhall(Northwestern University), Jonathan L. Finlay(The Ohio State University), Jeffery J. Auletta(Nationwide Children's Hospital)
Cited by 0
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas
|Nature Communications|2019|372
COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
|Journal of Infection|2021|248
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group.
|Journal of Clinical Oncology|1996|203
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer Group.
|Journal of Clinical Oncology|1998|188